Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
2(20%)
Results Posted
0%(0 trials)

Phase Distribution

Ph early_phase_1
2
20%
Ph phase_2
3
30%
Ph phase_1
1
10%
Ph phase_4
3
30%

Phase Distribution

3

Early Stage

3

Mid Stage

3

Late Stage

Phase Distribution9 total trials
Early Phase 1First-in-human
2(22.2%)
Phase 1Safety & dosage
1(11.1%)
Phase 2Efficacy & side effects
3(33.3%)
Phase 4Post-market surveillance
3(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(6)
Other(2)

Detailed Status

Completed6
unknown2
Recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (22.2%)
Phase 11 (11.1%)
Phase 23 (33.3%)
Phase 43 (33.3%)

Trials by Status

completed660%
unknown220%
recruiting110%
active_not_recruiting110%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DRUG
Total Trials
10